[FDMT] YoY Quarter Result on 31-Mar-2020 [#Q1]

Stock
[FDMT] 4D Molecular Therapeutics, Inc.
Announcement Date
30-Mar-2020
Financial Year
2020
Quarter
31-Mar-2020 [#Q1]
Profit Trend
QoQ- 18.34%
YoY- -59.36%
Quarter Report
FDMT's Result
FDMT's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Revenue 28 298 1,219 2,000 3,535 2,208 2,535 -52.77%
PBT -32,401 -28,682 -26,338 -16,406 -13,160 -8,258 -2,593 52.27%
Tax -0 -1,424 -154 -7 -130 0 0 -
NP -32,401 -27,258 -26,184 -16,406 -13,160 -8,258 -2,593 52.27%
Tax Rate - - - - - - - -
Total Cost 32,429 27,556 27,403 18,406 16,695 10,466 5,128 35.94%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
NP Margin -115,717.86 -9,146.98 -2,147.99 -820.30 -372.28 -374.00 -102.31 222.44%
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
EPS -0.66 -0.83 -0.81 -0.61 -0.89 -1.61 -0.52 4.04%
EPS Diluted -0.66 -0.83 -0.81 -0.61 -0.89 -1.61 -0.52 4.04%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.